1. Fannie Mae and Freddie Mac Cut the Proportion of Loans
As the Federal Housing Finance Agency is considering the downturn risk of the economy, Fannie Mae and Freddie Mac have been observed that shrinking the share of these loans in their business for three quarters and cutting loans for borrowers with 3% down payments.
Source: Wall Street Journal
2. Decade-long Trend Pulled Back
As we can see from the chart of the S&P 500 Index, the stock market entered a period of oscillation.
3. Big Drug companies Scramble For the huge Cancer Treatment Market Shares
Merck announced to acquire ArQule, who has leading results in blood-related cancers, with nearly $2.7 billion on Monday, as Sanofi SA said it will buy Synthorx, lead French pharmaceutical company, with $2.5 billion on the same day. Earlier this year, Bristol-Mayers completed its deal of acquiring Celgene, its rival, for $74 billion to create a cancer-drugs powerhouse, while Pfizer has bought Array BioPharma for $10.6 billion. These deals signal an increasingly intense battle in the cancer-drugs area, which has up to $123 billion markets, according to a market research by EvaluatePharma.
Today's Topic: Employment Numbers of November
Dear readers from Moomoo,
We are planning to make this every-day key points before the bell a more efficient and digestible one. And we’d love you to help us to grow. Please feel free to leave comments or questions. Any suggestions, ideas, or complaints will be appreciated.
Sincerely,
Editor/Celeste
1.房利美和房地美降低贷款比例
由于联邦住房金融机构正在考虑经济下滑的风险，据观察，房利美和房地美将这些贷款在其业务中的份额缩减了三个季度，并以3%的首付削减了对借款人的贷款。
资料来源：“华尔街日报”
2.十年来的趋势倒退
从标准普尔500指数的图表可以看出，股市进入了震荡期。
3.大型制药公司争夺巨大的癌症治疗市场份额
周一，默克宣布以近27亿美元收购阿尔库勒，后者在血液相关癌症方面取得了领先的业绩。赛诺菲SA表示，将在同一天以25亿美元收购法国领先的制药公司辛索克斯(Synthorx)。今年早些时候，布里斯托-梅耶斯完成了以740亿美元收购其竞争对手Celgene的交易，以建立一个癌症药物强国，而辉瑞公司则以106亿美元收购了阵列生物制药公司。根据价值制药公司的一项市场研究，这些交易标志着在癌症药物领域的竞争日益激烈，该领域的市场价值高达1，330亿美元。
今日主题：十一月就业人数
来自Moomoo的读者，
我们计划每天在钟声前把这个关键点变成更有效率和更容易消化的要点。我们希望你能帮助我们成长。请随时留下评论或问题。如有任何建议、意见或投诉，将不胜感激。
真诚地，
编辑/塞莱斯特
Chinese Translation:
This service is provided by Mr.Translator (Tencent)